Log in to search using one of your social media accounts:

 

Soy reduces side effects of breast cancer treatment
Soy milk, tofu and edamame can help symptoms such as hot flashes and night sweats, found Georgetown Lombardi Comprehensive Cancer Center in Washington. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2017 Category: Consumer Health News Source Type: news

Poor Screening Adherence May Worsen Breast Cancer Outcomes Poor Screening Adherence May Worsen Breast Cancer Outcomes
Women who forgo mammography screening may comply less to breast cancer treatment and may have worse outcomes, suggest two European studies, which also found that rates of screening may be falling.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Has Your Doc Been Touched by Breast Cancer? It Could Influence Care
MONDAY, Dec. 11, 2017 -- Having a personal connection to breast cancer seems to make doctors more likely to recommend routine breast cancer screenings, a new study finds. A survey of 848 doctors across the United States found they were more likely... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2017 Category: General Medicine Source Type: news

News Analysis: Birth Control Pills Protect Against Cancer, Too
A small increased risk of breast cancer among women using hormonal contraceptives may be more than offset by the pills ’ protective effects. (Source: NYT Health)
Source: NYT Health - December 11, 2017 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Women and Girls Breast Cancer Birth Control and Family Planning Hormones Estrogen Pregnancy and Childbirth Source Type: news

More Younger Women Opting for Bilateral Mastectomy More Younger Women Opting for Bilateral Mastectomy
Rates of bilateral mastectomy for breast cancer are increasing regardless of the success of chemotherapy, particularly in younger and white women and in those with private/managed health insurance.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Modest Weight Loss Cuts Postmenopausal Breast Cancer Risk Modest Weight Loss Cuts Postmenopausal Breast Cancer Risk
Women who lose just 5% of their body weight after the menopause may experience a significant reduction in their risk of developing breast cancer vs women with stable weight, say US researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Breast cancer treatment: Can Brussels sprouts, soy reduce side effects?
Researchers have found that soy and cruciferous vegetables, such as Brussels sprouts, could reduce the long-term side effects of breast cancer treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Findings and Factoids from SABCS 2017: Test Your Knowledge
(MedPage Today) -- The findings flowed from the San Antonio Breast Cancer Symposium, but were you paying attention? (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 11, 2017 Category: American Health Source Type: news

Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
INDIANAPOLIS, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that Kimberly Blackwell, M.D., one of the nation's leading breast cancer researchers, will join Lilly Oncology as vice president of ... Biopharmaceuticals, Oncology, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

First Data on Older Breast Cancer Pts on CDK4/6 Inhibitors First Data on Older Breast Cancer Pts on CDK4/6 Inhibitors
Giving CDK4/6 inhibitors to breast cancer patients aged ≥ 70 years yields a similar progression-free survival to that seen in younger women, although the toxicity is more severe, say FDA researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer screening – is it worth it?
All women aged between 50 and 70 are offered screening for breast cancer. But how effective is it at stopping deaths – and might it actually do more harm than good?Many of us will know someone who had breast cancer found at screening. The cancer seen on a mammogram may have been microscopic, so early in its malignant life that it hadn ’t broken through the wall of its milk duct. Thank heavens, then, for breast screening, which is offered to all women between 50 and 70 in the UK and other countries. It is promoted enthusiastically as lifesaving, but does it deliver on its promise? And are the randomised con...
Source: Guardian Unlimited Science - December 11, 2017 Category: Science Authors: Luisa Dillner Tags: Health & wellbeing Life and style Breast cancer Society Cancer research Medical research Science Source Type: news

Innovative Breast Cancer Awareness and Advocacy Campaign Innovative Breast Cancer Awareness and Advocacy Campaign
Learn how breast health and cancer awareness can be promoted effectively in communities.Journal of Global Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

British gran is first to get new breast cancer treatment
Anna Jones is a 65-year-old British woman who has become the first in the world to be given a revolutionary breast cancer treatment through a combination of immunotherapy drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2017 Category: Consumer Health News Source Type: news

Drug suppresses spread of breast cancer caused by stem-like cells
(University of California - San Diego) Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report University of California San Diego School of Medicine and Moores Cancer Center researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2017 Category: Cancer & Oncology Source Type: news

Soy, cruciferous vegetables associated with fewer common breast cancer treatment side effects
(Georgetown University Medical Center) Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, say a team of scientists. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2017 Category: International Medicine & Public Health Source Type: news

The New Health Care: Birth Control and Breast Cancer: Putting the Risk in Perspective
The risk can ’ t be ignored but isn ’ t as great as it may seem from a recent study. (Source: NYT Health)
Source: NYT Health - December 10, 2017 Category: Consumer Health News Authors: AARON E. CARROLL Tags: Breast Cancer Birth Control and Family Planning Hormones Source Type: news

The New Health Care: Birth Control and Breast Cancer: Look Beyond the Headlines
It ’ s impossible to look at individual harms alone and make good health decisions. (Source: NYT Health)
Source: NYT Health - December 10, 2017 Category: Consumer Health News Authors: AARON E. CARROLL Tags: Breast Cancer Birth Control and Family Planning Hormones Source Type: news

600,000 women ditch pill after fears links breast cancer
Official NHS figures reveal that between 2011 and 2015, the number of women in England taking the Pill fell by almost a quarter. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2017 Category: Consumer Health News Source Type: news

Life-changing injection will 'add months' breast cancer
The life-changing treatment, taken as an injection every three weeks, offers a last chance for women with triple negative breast cancer (TNBC) who have exhausted other options. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2017 Category: Consumer Health News Source Type: news

SABCS: Biannual breast MRI best for young women at high risk
For young women with a high genetic risk of breast cancer, twice-yearly MRI...Read more on AuntMinnie.comRelated Reading: At-risk women not receiving breast MRI scans Breast MRI neural network predicts treatment response Deep learning with breast MRI helps with lesion detection Breast MRI neural networks predict recurrence scores ACR releases breast cancer screening criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 9, 2017 Category: Radiology Source Type: news

Acupuncture Helps AI Pain; Insurers Should Cover, Say Trialists Acupuncture Helps AI Pain; Insurers Should Cover, Say Trialists
In a randomized controlled trial that was praised as well designed, acupuncture improved pain and stiffness among breast cancer patients taking aromatase inhibitors (AIs).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Older Women Do Well with New Breast Cancer Drugs (CME/CE)
(MedPage Today) -- Patients over age 70 respond to CDK 4/6 inhibitors (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 8, 2017 Category: OBGYN Source Type: news

Cell Repair Blocker Promising in Breast Cancer (CME/CE)
(MedPage Today) -- PARP inhibitor delays progression in advanced disease (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 8, 2017 Category: OBGYN Source Type: news

Statins May Up Breast Cancer-Specific and Overall Survival Statins May Up Breast Cancer-Specific and Overall Survival
Statins may improve breast cancer outcomes whether women take them before or after their diagnosis and extend overall survival as well.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Higher Breast Cancer Risk Tied To The Pill Might Be Small But Shouldn't Be Dismissed
A new study of 1.8 million women found that hormonal contraception users had a higher risk of breast cancer. Although the increased risk translated to only one extra case of breast cancer out of every 7,690 hormonal contraceptive users, the finding should help inform women's birth control decisions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 8, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Source Type: news

Higher Breast Cancer Risk Tied To The Pill, Hormonal IUD, Might Be Small But Shouldn't Be Dismissed
A new study of 1.8 million women found that hormonal contraception users had a higher risk of breast cancer. Although the increased risk translated to only one extra case of breast cancer out of every 7,690 hormonal contraceptive users, the finding should help inform women's birth control decisions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 8, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Source Type: news

At-risk women not receiving breast MRI scans
Community practices are not following guidelines for breast cancer screening...Read more on AuntMinnie.comRelated Reading: Breast MRI neural network predicts treatment response Deep learning with breast MRI helps with lesion detection Breast MRI neural networks predict recurrence scores ACR releases breast cancer screening criteria Deep learning with breast MRI boosts lesion detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2017 Category: Radiology Source Type: news

SABCS: Modest Weight Loss Cuts Breast CA Risk Post Menopause
Postmenopausal women with weight gain had increased risk of triple - negative breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Nursing, Oncology, Pathology, Radiology, Surgery, Conference News, Source Type: news

Breast cancer: Women who lose weight after the menopause may reduce their risk
WOMEN who lose weight after the menopause may have a significantly reduced chance of developing breast cancer, according to research today. (Source: Daily Express - Health)
Source: Daily Express - Health - December 8, 2017 Category: Consumer Health News Source Type: news

Just a Little Weight Loss May Cut Breast Cancer Risk
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Oncology, Nutrition, News, Source Type: news

Fewer Hormonal Meds for Breast Cancer Patients?
Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - December 8, 2017 Category: Consumer Health News Source Type: news

A Little Weight Loss May Cut Breast Cancer Risk
It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - December 8, 2017 Category: Consumer Health News Source Type: news

Only 2 Years of Extended Anastrozole Needed in Breast Cancer Only 2 Years of Extended Anastrozole Needed in Breast Cancer
After an initial 5 years of endocrine therapy in postmenopausal cancer, a further 2 years of the aromatase inhibitor is sufficient, instead of another 5 years, suggest new results.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Women could avoid breast cancer if they lose weight
Researchers from the City of Hope National Medical Center in Duarte, California, build on previous studies linking estrogen stored in fat tissue to an increased breast cancer risk. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2017 Category: Consumer Health News Source Type: news

Pfizer breast cancer drug superior to chemotherapy in late stage study
(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. (Source: Reuters: Health)
Source: Reuters: Health - December 8, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Mammography Fails to Lower Rates of Advanced Breast Cancer Mammography Fails to Lower Rates of Advanced Breast Cancer
In the Netherlands, 24 years of mammography screening had no effect on reducing rates of advanced cancer but resulted in overdiagnosis in a third of women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Intriguing': 9 Weeks of Trastuzumab for Breast Cancer'Intriguing': 9 Weeks of Trastuzumab for Breast Cancer
Nine weeks of therapy fell short of being noninferior to 12 months for the primary outcome, but overall survival was comparable, and the shorter course is less toxic and less expensive.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Just a Little Weight Loss May Cut Breast Cancer Risk
FRIDAY, Dec. 8, 2017 -- It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests. Researchers found that a 5 percent or greater weight loss after menopause could lower the odds of breast cancer by about... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2017 Category: General Medicine Source Type: news

Dying mother starts petition to lower age of breast screening
A mother dying from breast cancer has set up a campaign to expand a screening programme. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 8, 2017 Category: Consumer Health News Source Type: news

Just a Little Weight Loss May Cut Breast Cancer Risk
Title: Just a Little Weight Loss May Cut Breast Cancer RiskCategory: Health NewsCreated: 12/8/2017 12:00:00 AMLast Editorial Review: 12/8/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 8, 2017 Category: Cancer & Oncology Source Type: news

For Breast Cancer Patients, Less Time on Hormonal Meds?
Title: For Breast Cancer Patients, Less Time on Hormonal Meds?Category: Health NewsCreated: 12/7/2017 12:00:00 AMLast Editorial Review: 12/8/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 8, 2017 Category: Cancer & Oncology Source Type: news

Study results offer another boon for PARP inhibitors in treatment of advanced breast cancer
(University of Pennsylvania School of Medicine) Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, M.D., executive director of the Basser Center for BRCA at Penn's Abramson Cancer Center, will present new results from the Mediola and OlympiAD trials showing continued success of treating BRCA-related metastatic breast cancer with the PARP inhibitor olaparib with limited side effects for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

For women with genetic risk, bi-annual MRI beats mammograms
(University of Chicago Medical Center) Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram. DCE-MRI every six months performed well for early detection of invasive breast cancer in high-risk women. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 8, 2017 Category: Biology Source Type: news

Lymph node surgery may raise risk of arm morbidity in younger women
(American Association for Cancer Research) Younger breast cancer patients who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received sentinel lymph node biopsies, according to data presented at the 2017 San Antonio Breast Cancer Symposium, held Dec. 5-9. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

Including diagnosis related costs, 3-D mammography costs less than digital mammography
(University of Pennsylvania School of Medicine) Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it actually may help rein in cancer screening costs, according to preliminary findings (PD7-05) presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the 2017 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA
(University of Texas M. D. Anderson Cancer Center) In a randomized, Phase III trial led by researchers at the University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer
(ECOG-ACRIN Cancer Research Group) Late recurrence five+ years after surgery accounts for at least half of all breast cancer recurrences. There are no tests that identify who is at highest risk. ECOG-ACRIN Cancer Research Group researchers studied a blood test for circulating tumor cells, finding that in women cancer-free five after diagnosis, 5% had a positive test, which was associated with a 35% recurrence risk after two years, compared with only 2% with a negative test. Findings require follow-up. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

Ribociclib Effective in Younger Breast Cancer Patients Too Ribociclib Effective in Younger Breast Cancer Patients Too
In premenopausal women with HR-positive, HER2-negative advanced breast cancer, the CDK4/6 inhibitor plus endocrine therapy dramatically improves progression-free survival compared with endocrine therapy alone.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Just a Little Weight Loss May Cut Breast Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

A better mammogram? Study puts 3D scans to the test
Health officials are starting a huge study to tell if the newer, sometimes pricier scans really improve screening for breast cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 7, 2017 Category: Consumer Health News Source Type: news